CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients

<table>Overall survival in the groups of patients having and lacking <i>herpes</i> virus (CMV and/or EBV and/or HHV6) reactivations/infections.</table>

Bone Marrow Research

fig1

Figure 1

Figure 1: CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients 